Anti-CD1d antibody [NOR3.2 (NOR3.2/13.17)] (ab11076)

Publishing research using ab11076? Please let us know so that we can cite the reference in this datasheet.

ab11076 has been referenced in 6 publications.

  • Ascierto ML  et al. Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med 11:145 (2013). IHC-P . PubMed: 23758773
  • Xu C  et al. Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma. Am J Hematol 85:539-41 (2010). IHC . PubMed: 20575029
  • Allen CE  et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184:4557-67 (2010). IHC-Fr ; Human . PubMed: 20220088
  • Motohashi S  et al. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol 182:2492-501 (2009). Flow Cyt ; Human . PubMed: 19201905
  • Matsumoto J  et al. Expression of surface CD1d in the extravillous trophoblast cells of early gestational placenta is downregulated in a manner dependent on trophoblast differentiation. Biochem Biophys Res Commun 371:236-41 (2008). IHC-Fr ; Human . PubMed: 18433720
  • Shimizu K  et al. Evaluation of the function of human invariant NKT cells from cancer patients using alpha-galactosylceramide-loaded murine dendritic cells. J Immunol 177:3484-92 (2006). Flow Cyt ; Human . PubMed: 16920991

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"